<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30180850</PMID><DateCompleted><Year>2018</Year><Month>10</Month><Day>11</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1546-0096</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Sep</Month><Day>04</Day></PubDate></JournalIssue><Title>Pediatric rheumatology online journal</Title><ISOAbbreviation>Pediatr Rheumatol Online J</ISOAbbreviation></Journal><ArticleTitle>A case of Henoch-Schonlein Purpura with dilated coronary arteries.</ArticleTitle><Pagination><StartPage>54</StartPage><MedlinePgn>54</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">54</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12969-018-0270-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Henoch-Schonlein Purpura (HSP) is one of the most common vasculitides of childhood, with 10-20 cases per 100,000 children. It frequently occurs following an infectious trigger and involves IgA and C3 deposition in small vessel walls. HSP is characterized by palpable purpura plus IgA deposition on biopsy, arthritis/arthralgia, renal involvement (hematuria and/or proteinuria), and/or abdominal pain. It is not generally recognized as a cause of dilated coronary arteries.</AbstractText><AbstractText Label="CASE PRESENTATION" NlmCategory="METHODS">We describe the first reported case of HSP presenting with dilated coronary arteries. This patient is a nine-year-old previously healthy Caucasian male who presented with 1 week of petechiae on his lower legs, knee and ankle arthritis, and abdominal pain without fever, consistent with HSP. An echocardiogram revealed coronary dilation, including the left main (5.32&#xa0;mm, Z score&#x2009;+&#x2009;4.25) and left anterior descending (LAD) (3.51&#xa0;mm, Z score&#x2009;+&#x2009;2.64) coronary arteries. He received high dose aspirin, IVIG, and infliximab with normalization of the LAD. Skin biopsy revealed leukocytoclastic vasculitis with positive IgA staining. He was Rhinovirus/Enterovirus positive with Group A Streptococcus on throat culture.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Cardiac findings, while rare, can exist in HSP. Coronary dilation appeared to respond to our hospital protocol's Kawasaki Disease (KD) therapy, possibly indicating an overlap in HSP and KD pathophysiology. This case, along with prior reports of dilated coronaries in systemic juvenile idiopathic arthritis (SJIA), highlights the importance of considering other sources of systemic inflammation, in addition to KD, when coronary dilation is identified. The appropriate therapy, follow-up, and prognosis for our patient are not clear, as further studies are needed to determine the natural course of these findings.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bloom</LastName><ForeName>Jessica L</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0002-7645-2084</Identifier><AffiliationInfo><Affiliation>Department of Pediatric Rheumatology, Children's Hospital Colorado, 13123 East 16th Avenue, B311, Aurora, CO, 80045, USA. Jessica.Bloom@childrenscolorado.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Darst</LastName><ForeName>Jeffrey R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Pediatric Rheumatology, Children's Hospital Colorado, 13123 East 16th Avenue, B311, Aurora, CO, 80045, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prok</LastName><ForeName>Lori</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pediatric Rheumatology, Children's Hospital Colorado, 13123 East 16th Avenue, B311, Aurora, CO, 80045, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soep</LastName><ForeName>Jennifer B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Department of Pediatric Rheumatology, Children's Hospital Colorado, 13123 East 16th Avenue, B311, Aurora, CO, 80045, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>09</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Pediatr Rheumatol Online J</MedlineTA><NlmUniqueID>101248897</NlmUniqueID><ISSNLinking>1546-0096</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000894">Anti-Inflammatory Agents, Non-Steroidal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018501">Antirheumatic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016756">Immunoglobulins, Intravenous</NameOfSubstance></Chemical><Chemical><RegistryNumber>B72HH48FLU</RegistryNumber><NameOfSubstance UI="D000069285">Infliximab</NameOfSubstance></Chemical><Chemical><RegistryNumber>R16CO5Y76E</RegistryNumber><NameOfSubstance UI="D001241">Aspirin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000894" MajorTopicYN="N">Anti-Inflammatory Agents, Non-Steroidal</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018501" MajorTopicYN="N">Antirheumatic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001241" MajorTopicYN="N">Aspirin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003324" MajorTopicYN="N">Coronary Artery Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003331" MajorTopicYN="N">Coronary Vessels</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004452" MajorTopicYN="N">Echocardiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011695" MajorTopicYN="N">IgA Vasculitis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016756" MajorTopicYN="N">Immunoglobulins, Intravenous</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069285" MajorTopicYN="N">Infliximab</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012867" MajorTopicYN="N">Skin</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Abdominal pain</Keyword><Keyword MajorTopicYN="N">Arthritis</Keyword><Keyword MajorTopicYN="N">Coronary artery dilation</Keyword><Keyword MajorTopicYN="N">Dilated coronary arteries</Keyword><Keyword MajorTopicYN="N">Henoch-Schonlein Purpura (HSP)</Keyword><Keyword MajorTopicYN="N">IgA</Keyword><Keyword MajorTopicYN="N">Kawasaki disease (KD)</Keyword><Keyword MajorTopicYN="N">Petechiae</Keyword><Keyword MajorTopicYN="N">Purpura</Keyword><Keyword MajorTopicYN="N">Vasculitis</Keyword></KeywordList><CoiStatement>ETHICS APPROVAL AND CONSENT TO PARTICIPATE: Not Applicable. CONSENT FOR PUBLICATION: Written consent obtained. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER&#x2019;S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>4</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>9</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>9</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>9</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30180850</ArticleId><ArticleId IdType="pmc">PMC6123917</ArticleId><ArticleId IdType="doi">10.1186/s12969-018-0270-9</ArticleId><ArticleId IdType="pii">10.1186/s12969-018-0270-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Petty RE, Lindsley CB, et al. Cassidys textbook of pediatric rheumatology. 7. Philadelphia: Elsevier; 2016.</Citation></Reference><Reference><Citation>Tizard EJ, Hamilton-Ayres MJJ. Henoch Schonlein purpura. Arch Dis Child Educ Pract. 2008;93(1):1&#x2013;8. doi: 10.1136/adc.2004.066035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.2004.066035</ArticleId><ArticleId IdType="pubmed">18208978</ArticleId></ArticleIdList></Reference><Reference><Citation>Saulsbury FT. Clinical update: Henoch-Sch&#xf6;nlein purpura. Lancet. 2007;369(9566):976&#x2013;978. doi: 10.1016/S0140-6736(07)60474-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(07)60474-7</ArticleId><ArticleId IdType="pubmed">17382810</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozen S. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. 2005;65(7):936&#x2013;941. doi: 10.1136/ard.2005.046300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2005.046300</ArticleId><ArticleId IdType="pmc">PMC1798210</ArticleId><ArticleId IdType="pubmed">16322081</ArticleId></ArticleIdList></Reference><Reference><Citation>Soliman M, Laxer R, et al. Imaging of systemic vasculitis in childhood. Pediatr Radiol. 2015;45(8):1110&#x2013;1125. doi: 10.1007/s00247-015-3339-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00247-015-3339-3</ArticleId><ArticleId IdType="pubmed">26198677</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang Y, Park J-S, et al. Differences in clinical manifestations and outcomes between adult and child patients with Henoch-Sch&#xf6;nlein Purpura. J Korean Med Sci. 2014;29(2):198. doi: 10.3346/jkms.2014.29.2.198.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2014.29.2.198</ArticleId><ArticleId IdType="pmc">PMC3923997</ArticleId><ArticleId IdType="pubmed">24550645</ArticleId></ArticleIdList></Reference><Reference><Citation>Pillebout E. Henoch-Schonlein Purpura in adults: outcome and prognostic factors. J Am Soc Nephrol. 2002;13(5):1271&#x2013;1278. doi: 10.1097/01.ASN.0000013883.99976.22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ASN.0000013883.99976.22</ArticleId><ArticleId IdType="pubmed">11961015</ArticleId></ArticleIdList></Reference><Reference><Citation>Kereiakes D, Ports T, et al. Endomyocardial biopsy in Henouch-Schonlein purpura. Am Heart J. 1984;107(2):382&#x2013;385. doi: 10.1016/0002-8703(84)90390-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-8703(84)90390-9</ArticleId><ArticleId IdType="pubmed">6364755</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmichael P, Brun E, et al. A fatal case of bowel and cardiac involvement in Henoch-Schonlein purpura. Nephrol Dial Transplant. 2002;17:497&#x2013;499. doi: 10.1093/ndt/17.3.497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/17.3.497</ArticleId><ArticleId IdType="pubmed">11865100</ArticleId></ArticleIdList></Reference><Reference><Citation>Satoh M, Mikuniya A, et al. A case of Schonlein-Henoch Purpura with myocardial complications. Kokyu To Junkan. 1991;39(3):273&#x2013;277.</Citation><ArticleIdList><ArticleId IdType="pubmed">2047607</ArticleId></ArticleIdList></Reference><Reference><Citation>Agraharkar M, Gokahle S, et al. Cardiopulmonary Manifestations of Henoch-Schonlein Purpura. Am J Kidney Dis. 2000;35(2):319&#x2013;322. doi: 10.1016/S0272-6386(00)70344-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0272-6386(00)70344-1</ArticleId><ArticleId IdType="pubmed">10676734</ArticleId></ArticleIdList></Reference><Reference><Citation>Osman A, Mccreery CJ. Cardiac Vasculitis in Henoch-Schonlein Purpura. Circulation. 2000;101(5) 10.1161/01.cir.101.5.e69.</Citation><ArticleIdList><ArticleId IdType="pubmed">10662762</ArticleId></ArticleIdList></Reference><Reference><Citation>Lecutier MA. A case of the Schonlein-Henoch syndrome with Mycocardial necrosis. J Clin Path. 1952;5:336&#x2013;338. doi: 10.1136/jcp.5.4.336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jcp.5.4.336</ArticleId><ArticleId IdType="pmc">PMC1023672</ArticleId><ArticleId IdType="pubmed">13011221</ArticleId></ArticleIdList></Reference><Reference><Citation>Polizzotto MN, Gibbs SDJ, et al. Cardiac involvement in Henoch-Schonlein purpura. Intern Med J. 2006;36:328&#x2013;331. doi: 10.1111/j.1445-5994.2006.01061.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1445-5994.2006.01061.x</ArticleId><ArticleId IdType="pubmed">16650200</ArticleId></ArticleIdList></Reference><Reference><Citation>Lutz H, Ackermann T, et al. Henoch-Schonlein Purpura complicated by cardiac involvement: case report and review of the literature. Am J Kidney Dis. 2009;54(5):e9&#x2013;e15. doi: 10.1053/j.ajkd.2009.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2009.04.017</ArticleId><ArticleId IdType="pubmed">19535191</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai T, Matsumoto S. Anaphylacatoid Purpura with cardiac involvement. Arch Dis Child. 1970;45(243):727&#x2013;729. doi: 10.1136/adc.45.243.727.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.45.243.727</ArticleId><ArticleId IdType="pmc">PMC1647501</ArticleId><ArticleId IdType="pubmed">4249054</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellantoni A, Presti P, et al. Un caso pediatrico di porpora di Schoenlein-Henoch con segni clinici, sierologici ed elettrocardiografici di danno miocardico. G Ital Cardiol. 2013;14(9):622&#x2013;625.</Citation><ArticleIdList><ArticleId IdType="pubmed">23903281</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayakawa K, Shiohara T. Two cases of Henoch-Schonlein Purpura with transient myocardial ischemia. Acta Derm Venereol. 2003;83:393&#x2013;394. doi: 10.1080/00015550310012601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00015550310012601</ArticleId><ArticleId IdType="pubmed">14609119</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdel-Hadi O, Greenstone MA, et al. Myocardial infarction - a rare complication in Henoch-Schonlein purpura. Postgrad Med J. 1981;57(668):390&#x2013;392. doi: 10.1136/pgmj.57.668.390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/pgmj.57.668.390</ArticleId><ArticleId IdType="pmc">PMC2424899</ArticleId><ArticleId IdType="pubmed">7301688</ArticleId></ArticleIdList></Reference><Reference><Citation>Eleftheriadis D. Severe coronary artery disease in the setting of Henoch&#x2013;Schoenlein purpura. Int J Cardiol. 2007;118(2):262&#x2013;263. doi: 10.1016/j.ijcard.2006.07.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2006.07.023</ArticleId><ArticleId IdType="pubmed">17023082</ArticleId></ArticleIdList></Reference><Reference><Citation>Canpolat U, Yorgun H, et al. Myocardial infarction due to coronary thrombosis in a patient with Henoch&#x2013;Sch&#xf6;nlein purpura. Herz. 2012;37(7):801&#x2013;803. doi: 10.1007/s00059-012-3597-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00059-012-3597-x</ArticleId><ArticleId IdType="pubmed">22361720</ArticleId></ArticleIdList></Reference><Reference><Citation>Michas G, Grigoriou K, et al. A rare cause of myocarditis resulting in acute heart failure in the setting of Henoch&#x2013;Sch&#xf6;nlein purpura. Hell J Cardiol. 2017; 10.1016/j.hjc.2017.05.002.</Citation><ArticleIdList><ArticleId IdType="pubmed">28528257</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattoo TK, al-Mutair A, et al. Group A B-haemolitic streptococcal infection and Henoch-Schonlein Purpura with cardiac, renal and neurological complications. Ann Trop Paediatr. 1997;17(4):381&#x2013;386. doi: 10.1080/02724936.1997.11747914.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02724936.1997.11747914</ArticleId><ArticleId IdType="pubmed">9578800</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;ven H, &#xd6;zhan B, et al. A case of Henoch-Sch&#xf6;nlein purpura and rheumatic carditis with complete atrioventricular block. Eur J Pediatr. 2006;165(6):395&#x2013;397. doi: 10.1007/s00431-006-0094-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-006-0094-3</ArticleId><ArticleId IdType="pubmed">16534586</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin JI, Kim JH, et al. Cardiac manifestations of Henoch-Schoenlein purpura: IgA mediated vasculitis or rheumatic fever? Eur J Pediatr. 2006;166(6):627. doi: 10.1007/s00431-006-0273-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-006-0273-2</ArticleId><ArticleId IdType="pubmed">17047991</ArticleId></ArticleIdList></Reference><Reference><Citation>Ocal B, Karademir S, et al. Acute rheumatic carditis in Henoch-Schonlein purpura. Int J Cardiol. 2000;74:97&#x2013;98. doi: 10.1016/S0167-5273(00)00268-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0167-5273(00)00268-0</ArticleId><ArticleId IdType="pubmed">10912443</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisenstein EM, Navon-Elkan P. Acute rheumatic fever associated with Henoch-Schonlein purpura: report of three cases and review of the literature. Acta Paediatr. 2002;91:1265&#x2013;1267. doi: 10.1080/080352502320777559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/080352502320777559</ArticleId><ArticleId IdType="pubmed">12463331</ArticleId></ArticleIdList></Reference><Reference><Citation>Gairdner D. The Schonlein-Henoch syndrome (anaphylactois purpura) Q J Med. 1948;17(66):95&#x2013;122.</Citation><ArticleIdList><ArticleId IdType="pubmed">18870385</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung JT, Yang YH, et al. Leukocytoclastic vasculitis with severe cardiac involvement in an infant: a case report. Clin Rheumatol. 2008;27:945&#x2013;947. doi: 10.1007/s10067-008-0872-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-008-0872-6</ArticleId><ArticleId IdType="pubmed">18368289</ArticleId></ArticleIdList></Reference><Reference><Citation>James CA, Gonzalez I, et al. Severe mitral regurgitation in a child with Henoch-Sch&#xf6;nlein Purpura and pulmonary hemorrhage. Glob Pediatr Health. 2017;4:1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5582651</ArticleId><ArticleId IdType="pubmed">28894769</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Y, Yin L, et al. Incidence and clinical features of paediatric vasculitis in eastern China: 14-year retrospective study, 1999&#x2013;2013. J Int Med Res. 2016;44(3):710&#x2013;717. doi: 10.1177/0300060515621446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0300060515621446</ArticleId><ArticleId IdType="pmc">PMC5536695</ArticleId><ArticleId IdType="pubmed">27009025</ArticleId></ArticleIdList></Reference><Reference><Citation>Binstadt BA. Coronary Artery Dilation Among Patients Presenting With Systemic-Onset Juvenile Idiopathic Arthritis. Pediatrics. 2005;116(1) 10.1542/peds.2004-2190.</Citation><ArticleIdList><ArticleId IdType="pubmed">15930186</ArticleId></ArticleIdList></Reference><Reference><Citation>Newburger JW. Diagnosis, treatment, and long-term Management of Kawasaki Disease: a statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the young, american heart association. Circulation. 2004;110(17):2747&#x2013;2771. doi: 10.1161/01.CIR.0000145143.19711.78.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000145143.19711.78</ArticleId><ArticleId IdType="pubmed">15505111</ArticleId></ArticleIdList></Reference><Reference><Citation>Miura M, Mochizuki T, et al. A case of Kawasaki disease accompanied by Henoch-Sch&#xf6;nlein purpura. Clin Exp Rheumatol. 2004;22:377&#x2013;378.</Citation><ArticleIdList><ArticleId IdType="pubmed">15144140</ArticleId></ArticleIdList></Reference><Reference><Citation>Vedagiriswaran VV, Amperayani S, et al. A case of Henoch&#x2013;Sch&#xf6;nlein Purpura with Kawasaki disease. Indian J Pediatr. 2014;81(4):408&#x2013;409. doi: 10.1007/s12098-014-1395-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12098-014-1395-6</ArticleId><ArticleId IdType="pubmed">24652273</ArticleId></ArticleIdList></Reference><Reference><Citation>Heldrich FJ, Jodorkovsky RA, et al. Kawasaki syndrome: HUS and HSP complicating its course and management. Md Med J. 1987;36(9):764&#x2013;766.</Citation><ArticleIdList><ArticleId IdType="pubmed">3683104</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xe1;mez-Gonz&#xe1;lez LB, Rodr&#xed;guez-Lozano A, et al. Enfermedad de Kawasaki y p&#xfa;rpura de Henoch-Sch&#xf6;nlein: vasculitis frecuentes en una asociaci&#xf3;n infrecuente. Rev Alerg Mex. 2012;59(1):37&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">24007932</ArticleId></ArticleIdList></Reference><Reference><Citation>Porrello M, Gesu M, et al. Porpora di Schoenlein-Henoch dopo sindrome di Kawasaki: una predisposizione alle vasculiti? Ped Med Chir. 1998;20:71&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">9658425</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiler T, Chelliah A, et al. Novel finding of coronary ectasia in a case of acute rheumatic fever. Case Rep Pediatr. 2013;2013:1&#x2013;4. doi: 10.1155/2013/674174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/674174</ArticleId><ArticleId IdType="pmc">PMC3722906</ArticleId><ArticleId IdType="pubmed">23936712</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin JI, Lee JS. Severe coronary artery disease in Henoch&#x2013;Schoenlein purpura: superimposition of antiphospholipid or polyangitis overlap syndrome? Int J Cardiol. 2007;122(2):182&#x2013;183. doi: 10.1016/j.ijcard.2006.11.229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2006.11.229</ArticleId><ArticleId IdType="pubmed">17363087</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe K, Abe H, et al. Polyangitis overlap syndrome: a fatal case combined with adult Henoch-Schnonlein purpura and polyarteritis nodosa. Pathol Int. 2003;53:569&#x2013;573. doi: 10.1046/j.1440-1827.2003.01515.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1440-1827.2003.01515.x</ArticleId><ArticleId IdType="pubmed">12895238</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>